Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Geovax Labs (NQ: GOVX )

2.950 +0.250 (+9.26%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Geovax Labs

< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
GeoVax Announces Key Staff Appointments
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Exposures COVID-19
GeoVax to Report 2021 Financial Results on Wednesday, March 9, 2022 and Provide Corporate Update
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
GeoVax CEO Selected as a Recipient of the 2022 Georgia Titan 100
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
GeoVax to Present at the 2022 BIO CEO & Investor Digital Conference
Atlanta, GA - (NewMediaWire) - February 08, 2022 - GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company specializing in developing human vaccines and cancer immunotherapies, announced today that... 
Via NewMediaWire
Exposures COVID-19
GeoVax Announces Closing of $10 Million Private Placement
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers ATI Physical Therapy (NYSE:ATIP) stock increased by 22.7% to $3.73 during Friday's regular session. Trading volume for ATI Physical Therapy's stock is 14.3... 
Via Benzinga
GeoVax Announces $10 Million Private Placement
Atlanta, GA - (NewMediaWire) - January 14, 2022 - GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company specializing in developing human vaccines and cancer immunotherapies, announced today that it... 
Via NewMediaWire
GeoVax Retains CATO SMS To Manage Gedeptin Phase 1/2 Clinical Trial
GeoVax Labs, Inc. (NASDAQ: GOVX), a biotechnology company specializing in developing human vaccines and cancer immunotherapies, today announced the engagement of CATO SMS to... 
Via Benzinga
GeoVax Retains CATO SMS to Manage Gedeptin Phase 1/2 Clinical Trial
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
GeoVax Appoints Dr. Kelly McKee as Chief Medical Officer
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
GeoVax to Participate in Upcoming Life Sciences Investor Conferences
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Exposures COVID-19
GeoVax Issues Shareholder Update Letter
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
23 Stocks Moving in Tuesday's Pre-Market Session
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 62.1% to $1.05 in pre-market trading as the company issued a clinical and corporate update. NeuroBo Pharmaceuticals, Inc... 
Via Benzinga
GeoVax Initiates Phase 2 Trial For COVID-19 Vaccine Booster
GeoVax Labs Inc (NASDAQ: GOVX) initiated vaccine dosing in the Phase 2 portion of its Phase 1/2 trial of COH04S1 COVID-19 vaccine to target both the spike (S) and... 
Via Benzinga
GeoVax Announces Initiation of Phase 2 Clinical Trial for COVID-19 Vaccine Booster
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Exposures COVID-19
GeoVax Receives Notice of Allowance for Malaria Vaccine Patent
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Intellectual Property
Exposures Intellectual Property
GeoVax Presents Hemorrhagic Fever Vaccine Data at the World Vaccine & Immunotherapy Congress
Nonhuman Primate Testing of Sudan and Marburg Vaccine Candidates Demonstrates Efficacious Immune Response 
Via NewMediaWire
Topics Intellectual Property Regulatory Compliance
Exposures COVID-19 Intellectual Property Legal
GeoVax Presents COVID-19 Vaccine Data at the World Vaccine & Immunotherapy Congress
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Intellectual Property Regulatory Compliance
Exposures COVID-19 Intellectual Property Legal
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Good morning, traders! We're starting off the day right with a look at the biggest pre-market stock movers for Wednesday! 
Via InvestorPlace
23 Stocks Moving in Wednesday's Pre-Market Session
Gainers Skylight Health Group Inc. (NASDAQ: SLHG) rose 55.3% to $2.05 in pre-market trading after dipping around 10% on Tuesday. Skylight Health Group, last month, posted a... 
Via Benzinga
50 Biggest Movers From Yesterday
Gainers Krystal Biotech, Inc. (NASDAQ: KRYS) shares surged 121.7% to close at $88.24 on Monday after the company announced positive topline results from the GEM-3 Phase 3 trial... 
Via Benzinga
33 Stocks Moving In Monday's Mid-Day Session
Gainers Krystal Biotech, Inc. (NASDAQ: KRYS) shares jumped 116.4% to $86.13 after the company announced positive topline results from the GEM-3 Phase 3 trial of investigational... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers iSpecimen (NASDAQ:ISPC) stock moved upwards by 68.43% to $17.18 during Friday's pre-market session. The market value of their outstanding shares is at $119.6... 
Via Benzinga
25 Stocks Moving in Friday's Pre-Market Session
Gainers iSpecimen Inc. (NASDAQ: ISPC) rose 56.9% to $16.00 in pre-market trading. The company recently announced it has been contracted to support new advanced research on COVID-... 
Via Benzinga
56 Biggest Movers From Friday
Gainers iSpecimen Inc. (NASDAQ: ISPC) climbed 71.7% to settle at $17.51 on Friday. The company recently announced it has been contracted to support new advanced research on... 
Via Benzinga
GeoVax Presents COVID-19 Vaccine Data at the Vaccine World Asia Congress
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Regulatory Compliance
Exposures COVID-19 Legal Product Safety
48 Stocks Moving In Friday's Mid-Day Session
Gainers Allied Healthcare Products, Inc. (NASDAQ: AHPI) shares jumped 68% to $9.04. Shares of mask and protective apparel companies, including Allied Healthcare Products, traded... 
Via Benzinga
GeoVax Shares Surge After Cancer Vaccine Patent In US
GeoVax Labs Inc (NASDAQ: GOVX) has received a U.S. patent covering its vector platform for expressing tumor-associated antigens in virus-like particles (VLPs). The... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
80 Biggest Movers From Yesterday
Gainers BIMI International Medical Inc. (NASDAQ: BIMI) shares surged 55% to close at $1.00 on Tuesday as the company reported a narrower Q3 loss. Progenity, Inc. (NASDAQ: PROG)... 
Via Benzinga
53 Stocks Moving In Tuesday's Mid-Day Session
Gainers BIMI International Medical Inc. (NASDAQ: BIMI) jumped 65.7% to $1.0691 as the company reported a narrower Q3 loss. Progenity, Inc. (NASDAQ: PROG) shares climbed 35.5% to... 
Via Benzinga
< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.